Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

SUPN

Supernus Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · SUPN

All alert types
41.92 USD +0.08 +0.19%
As of Oct 30, 2026 Extended hours 41.92 0.00%
Bid
41.89 × 2
Ask
41.92 × 2
39.53 Day range 43.72
37.88 52-week range 57.00
YTD
-15.65%
1 year
-25.81%
Open
42.07
Prev close
41.84
Mkt cap
2.44B
Vol
2.82M
Avg vol
885.96K
EPS
-1.92
P/E
0.00
Div yield
0.00%
More statistics
Low
39.53
High
43.72
Forward P/E
9.79
Beta
0.55
Short ratio
5.36
Inst. own
105.93%
Dividend
0.00
Ex-div date
Earnings
Feb 23, 2027
50-d avg
42.61
200-d avg
47.34
1y target
60.50

5D chart

Chart tools
Interval
1m5m15m30m
SUPN five-day price chart39.540.741.943.144.3Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

5.83 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -73.1×
FY 2016: 13.7×FY 2017: 35.3×FY 2018: 15.6×FY 2019: 11.0×FY 2020: 10.4×FY 2021: 28.9×FY 2022: 31.6×FY 2023: 1201×FY 2024: 27.0×FY 2025: -73.1×
FY 2016 5y median 28.9× FY 2025
P/S 3.9×
FY 2016: 5.8×FY 2017: 6.7×FY 2018: 4.2×FY 2019: 3.2×FY 2020: 2.5×FY 2021: 2.7×FY 2022: 2.9×FY 2023: 2.6×FY 2024: 3.0×FY 2025: 3.9×
FY 2016 5y median 2.9× FY 2025
P/B 2.6×
FY 2016: 6.5×FY 2017: 7.6×FY 2018: 3.8×FY 2019: 2.1×FY 2020: 1.8×FY 2021: 1.9×FY 2022: 2.2×FY 2023: 1.7×FY 2024: 1.9×FY 2025: 2.6×
FY 2016 5y median 1.9× FY 2025
P/FCF 61.0×
FY 2016: 19.2×FY 2017: 18.0×FY 2018: 13.5×FY 2019: 8.9×FY 2020: 9.8×FY 2021: 12.4×FY 2022: 16.4×FY 2023: 14.3×FY 2024: 11.6×FY 2025: 61.0×
FY 2016 5y median 14.3× FY 2025
EV/EBITDA 63.9×
FY 2016: 20.5×FY 2017: 18.1×FY 2018: 12.3×FY 2019: 8.1×FY 2020: 6.9×FY 2021: 13.7×FY 2022: 14.8×FY 2023: 17.2×FY 2024: 11.0×FY 2025: 63.9×
FY 2016 5y median 14.8× FY 2025
EV/Sales 3.8×
FY 2016: 5.4×FY 2017: 6.4×FY 2018: 4.6×FY 2019: 3.7×FY 2020: 2.8×FY 2021: 3.1×FY 2022: 3.4×FY 2023: 2.5×FY 2024: 3.0×FY 2025: 3.8×
FY 2016 5y median 3.1× FY 2025
FCF Yield 1.6%
FY 2016: 5.2%FY 2017: 5.6%FY 2018: 7.4%FY 2019: 11.3%FY 2020: 10.2%FY 2021: 8.1%FY 2022: 6.1%FY 2023: 7.0%FY 2024: 8.6%FY 2025: 1.6%
FY 2016 5y median 7.0% FY 2025

Profitability

Gross Margin 89.6%
FY 2016: 94.4%FY 2017: 95.0%FY 2018: 96.2%FY 2019: 95.8%FY 2020: 89.9%FY 2021: 87.1%FY 2022: 86.9%FY 2023: 86.2%FY 2024: 88.2%FY 2025: 89.6%
FY 2016 5y median 87.1% FY 2025
Operating Margin -5.1%
FY 2016: 25.2%FY 2017: 32.9%FY 2018: 35.3%FY 2019: 37.8%FY 2020: 33.4%FY 2021: 14.8%FY 2022: 6.9%FY 2023: -0.9%FY 2024: 12.3%FY 2025: -5.1%
FY 2016 5y median 6.9% FY 2025
Net Margin -5.4%
FY 2016: 42.4%FY 2017: 19.0%FY 2018: 27.1%FY 2019: 28.8%FY 2020: 24.4%FY 2021: 9.2%FY 2022: 9.1%FY 2023: 0.2%FY 2024: 11.2%FY 2025: -5.4%
FY 2016 5y median 9.1% FY 2025
ROE -3.6%
FY 2016: 47.6%FY 2017: 21.4%FY 2018: 24.5%FY 2019: 19.0%FY 2020: 17.0%FY 2021: 6.5%FY 2022: 6.9%FY 2023: 0.1%FY 2024: 7.1%FY 2025: -3.6%
FY 2016 5y median 6.5% FY 2025
ROIC -2.6%
FY 2016: 23.7%FY 2017: 18.5%FY 2018: 14.0%FY 2019: 11.4%FY 2020: 10.4%FY 2021: 4.6%FY 2022: 3.2%FY 2023: -0.3%FY 2024: 5.7%FY 2025: -2.6%
FY 2016 5y median 3.2% FY 2025
ROA -2.7%
FY 2016: 29.5%FY 2017: 13.5%FY 2018: 11.4%FY 2019: 9.7%FY 2020: 8.4%FY 2021: 3.2%FY 2022: 3.6%FY 2023: 0.1%FY 2024: 5.4%FY 2025: -2.7%
FY 2016 5y median 3.2% FY 2025

Growth (YoY)

Revenue 8.6%
FY 2016: 48.9%FY 2017: 40.6%FY 2018: 35.3%FY 2019: -3.9%FY 2020: 32.5%FY 2021: 11.4%FY 2022: 15.1%FY 2023: -8.9%FY 2024: 8.9%FY 2025: 8.6%
FY 2016 FY 2025
Operating Income -145.1%
FY 2016: 206.9%FY 2017: 83.6%FY 2018: 45.1%FY 2019: 2.9%FY 2020: 16.9%FY 2021: -50.5%FY 2022: -46.4%FY 2023: -111.4%FY 2024: 1649.9%FY 2025: -145.1%
FY 2016 FY 2025
EPS (diluted) -151.5%
FY 2016: 528.6%FY 2017: -38.6%FY 2018: 89.8%FY 2019: 2.4%FY 2020: 12.4%FY 2021: -58.5%FY 2022: 6.1%FY 2023: -97.7%FY 2024: 5469.6%FY 2025: -151.5%
FY 2016 FY 2025
Free Cash Flow -73.1%
FY 2016: 117.2%FY 2017: 72.7%FY 2018: 13.8%FY 2019: 9.6%FY 2020: -3.9%FY 2021: -7.3%FY 2022: -6.9%FY 2023: -5.1%FY 2024: 54.9%FY 2025: -73.1%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 1.9×FY 2017: 1.9×FY 2018: 3.1×FY 2019: 2.9×FY 2020: 2.6×FY 2021: 1.9×FY 2022: 1.1×FY 2023: 1.7×FY 2024: 2.3×FY 2025: 1.9×
FY 2016 5y median 1.9× FY 2025
Quick Ratio 1.7×
FY 2016: 1.7×FY 2017: 1.7×FY 2018: 2.9×FY 2019: 2.8×FY 2020: 2.4×FY 2021: 1.6×FY 2022: 0.9×FY 2023: 1.4×FY 2024: 2.2×FY 2025: 1.7×
FY 2016 5y median 1.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.7×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -2.1×
FY 2016: -1.5×FY 2017: -0.7×FY 2018: 0.9×FY 2019: 1.1×FY 2020: 0.6×FY 2021: 1.7×FY 2022: 2.3×FY 2023: -0.4×FY 2024: -0.2×FY 2025: -2.1×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 10.6×FY 2017: 63.5×FY 2018: 8.0×FY 2019: 6.5×FY 2020: 7.3×FY 2021: 3.7×FY 2022: 6.5×FY 2023: -2.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31